Research Roundup: a rapid diagnostic for Ebola and fighting mosquito-borne diseases with soap and coconuts
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
Sign up to receive news and updates from GHTC.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
GHTC member the Drugs for Neglected Diseases initiative will test an affordable hepatitis C regimen in Malaysia and Thailand, with a guarantee from generic drug manufacturer Pharco Pharmaceuticals that, if successful, the product will be priced at no more than US$294 for the entire regimen.
As 2015 draws to a close, the Global Health Technologies Coalition is reflecting on the past year in global health innovation.
GHTC member TB Alliance announced last week the creation of the first-ever child-friendly tuberculosis (TB) medicines, which are currently undergoing regulatory review by the World Health Organization and should be available in early 2016.